Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000905718-17-000626

Director sold 32,368 shares at an average $16.23 ($525,302)

From the SEC's structured data for this filing

Trades in this filing

EMSTER KURT VON · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-06-22 Sale : show line 1 in the form −1,527 $16.21 $24,753 2,600,287 I
2017-06-23 Sale : show line 2 in the form −30,841 $16.23 $500,549 2,569,446 I
Open-market sales · 32,368 sh · avg $16.23 · $525,302
Loading xslF345X03/vonemster_form4jun222017.xml…